5,140 Shares in Astera Labs, Inc. $ALAB Purchased by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, HoldingsChannel reports. The firm purchased 5,140 shares of the company’s stock, valued at approximately $1,006,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of ALAB. Pinnacle Associates Ltd. bought a new position in shares of Astera Labs during the 3rd quarter valued at about $306,000. Ameriflex Group Inc. raised its holdings in shares of Astera Labs by 129.9% in the 3rd quarter. Ameriflex Group Inc. now owns 600 shares of the company’s stock worth $117,000 after purchasing an additional 339 shares in the last quarter. First Trust Advisors LP lifted its stake in Astera Labs by 140.4% during the third quarter. First Trust Advisors LP now owns 271,041 shares of the company’s stock valued at $53,070,000 after purchasing an additional 158,275 shares during the last quarter. Ramirez Asset Management Inc. acquired a new stake in Astera Labs during the third quarter valued at approximately $59,000. Finally, Left Brain Wealth Management LLC boosted its holdings in Astera Labs by 62.0% during the third quarter. Left Brain Wealth Management LLC now owns 4,375 shares of the company’s stock worth $857,000 after buying an additional 1,675 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $119.90 on Friday. The company has a market cap of $20.41 billion, a PE ratio of 98.28, a price-to-earnings-growth ratio of 2.45 and a beta of 1.74. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The firm has a 50 day simple moving average of $149.08 and a 200 day simple moving average of $168.55.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the previous year, the company posted $0.37 EPS. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have issued reports on ALAB shares. Barclays set a $165.00 price target on shares of Astera Labs in a research report on Thursday, January 15th. Morgan Stanley reissued an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research note on Wednesday, December 3rd. Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Northland Securities boosted their target price on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Finally, Royal Bank Of Canada started coverage on Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price for the company. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $195.89.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer directly owned 192,083 shares in the company, valued at $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 224,292 shares of company stock valued at $27,676,069 over the last quarter. 12.50% of the stock is owned by insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.